TY - JOUR
T1 - Allopatric tuberculosis host-pathogen relationships are associated with greater pulmonary impairment
AU - Pasipanodya, Jotam G.
AU - Moonan, Patrick K.
AU - Vecino, Edgar
AU - Miller, Thaddeus L.
AU - Fernandez, Michel
AU - Slocum, Philip
AU - Drewyer, Gerry
AU - Weis, Stephen E.
N1 - Funding Information:
This work was made possible by the cooperation of the Tarrant County Public Health Department and the University of North Texas Health Science Center at Fort Worth, as well as both the U.S. Centers for Disease Control and Prevention. This research did not receive direct funding from these or other sources; however, the Tuberculosis Epidemiologic Studies Consortium and the Tuberculosis Trials Consortium of the CDC provided salary support for Drs. Fernandez, Miller, Pasipanodya, Vecino, and Weis, and Ms. Drewyer, although neither consortium directly funded this study nor had any role in study design, data collection, data analysis, data interpretation, nor writing this report. The authors have no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article. We thank Drs. Juliana Grant, Michael Iademarco, Phil LoBue, Eugene McCray, and Tom Navin for their thoughtful review and helpful comments to the manuscript.
PY - 2013/6
Y1 - 2013/6
N2 - Background: Host pathogen relationships can be classified as allopatric, when the pathogens originated from separate, non-overlapping geographic areas from the host; or sympatric, when host and pathogen shared a common ancestral geographic location. It remains unclear if host-pathogen relationships, as defined by phylogenetic lineage, influence clinical outcome. We sought to examine the association between allopatric and sympatric phylogenetic Mycobacterium tuberculosis lineages and pulmonary impairment after tuberculosis (PIAT). Methods: Pulmonary function tests were performed on patients 16. years of age and older who had received ≥20. weeks of treatment for culture-confirmed M. tuberculosis complex. Forced Expiratory Volume in 1. min (FEV1) ≥80%, Forced Vital Capacity (FVC) ≥80% and FEV1/FVC >70% of predicted were considered normal. Other results defined pulmonary impairment. Spoligotype and 12-locus mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) were used to assign phylogenetic lineage. PIAT severity was compared between host-pathogen relationships which were defined by geography and ethnic population. We used multivariate logistic regression modeling to calculate adjusted odds ratios (aOR) to assess the association between phylogenetic lineage and PIAT. Results: Self-reported continental ancestry was correlated with Mycobacterium. tuberculosis lineage (p<. 0.001). In multivariate analyses adjusting for phylogenetic lineage, age and smoking, the overall aOR for subjects with allopatric host-pathogen relationships and PIAT was 1.8 (95% confidence interval [CI]: 1.1, 2.9) compared to sympatric relationships. Smoking >30. pack-years was also associated with PIAT (aOR: 3.2; 95% CI: 1.5, 7.2) relative to smoking <1. pack-years. Conclusions: PIAT frequency and severity varies by host-pathogen relationship and heavy cigarette consumption, but not phylogenetic lineage alone. Patients who had disease resulting from allopatric-host-pathogen relationship were more likely to have PIAT than patients with disease from sympatric-host-pathogen relationship infection. Further study of this association may identify ways that treatment and preventive efforts can be tailored to specific lineages and racial/ethnic populations.
AB - Background: Host pathogen relationships can be classified as allopatric, when the pathogens originated from separate, non-overlapping geographic areas from the host; or sympatric, when host and pathogen shared a common ancestral geographic location. It remains unclear if host-pathogen relationships, as defined by phylogenetic lineage, influence clinical outcome. We sought to examine the association between allopatric and sympatric phylogenetic Mycobacterium tuberculosis lineages and pulmonary impairment after tuberculosis (PIAT). Methods: Pulmonary function tests were performed on patients 16. years of age and older who had received ≥20. weeks of treatment for culture-confirmed M. tuberculosis complex. Forced Expiratory Volume in 1. min (FEV1) ≥80%, Forced Vital Capacity (FVC) ≥80% and FEV1/FVC >70% of predicted were considered normal. Other results defined pulmonary impairment. Spoligotype and 12-locus mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) were used to assign phylogenetic lineage. PIAT severity was compared between host-pathogen relationships which were defined by geography and ethnic population. We used multivariate logistic regression modeling to calculate adjusted odds ratios (aOR) to assess the association between phylogenetic lineage and PIAT. Results: Self-reported continental ancestry was correlated with Mycobacterium. tuberculosis lineage (p<. 0.001). In multivariate analyses adjusting for phylogenetic lineage, age and smoking, the overall aOR for subjects with allopatric host-pathogen relationships and PIAT was 1.8 (95% confidence interval [CI]: 1.1, 2.9) compared to sympatric relationships. Smoking >30. pack-years was also associated with PIAT (aOR: 3.2; 95% CI: 1.5, 7.2) relative to smoking <1. pack-years. Conclusions: PIAT frequency and severity varies by host-pathogen relationship and heavy cigarette consumption, but not phylogenetic lineage alone. Patients who had disease resulting from allopatric-host-pathogen relationship were more likely to have PIAT than patients with disease from sympatric-host-pathogen relationship infection. Further study of this association may identify ways that treatment and preventive efforts can be tailored to specific lineages and racial/ethnic populations.
KW - Genotypes
KW - Lineage
KW - Pulmonary impairment
KW - Race/ethnicity
KW - Tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=84876460596&partnerID=8YFLogxK
U2 - 10.1016/j.meegid.2013.02.015
DO - 10.1016/j.meegid.2013.02.015
M3 - Article
C2 - 23501297
AN - SCOPUS:84876460596
SN - 1567-1348
VL - 16
SP - 433
EP - 440
JO - Infection, Genetics and Evolution
JF - Infection, Genetics and Evolution
ER -